seen from United States
seen from United States
seen from Sweden
seen from Togo
seen from United States
seen from United States
seen from United States
seen from Germany
seen from United States
seen from United States
seen from United States
seen from United States
seen from United Kingdom
seen from United States
seen from United States
seen from T1
seen from United States
seen from Ukraine
seen from United Kingdom
seen from Yemen
BRIEF-Janssen seeks expanded use of Darzalex from EMA Nov 21 (Reuters) - Janssen-Cilag International NV: * Says submission of type II variation application to European Medicines Agency, for immunotherapy Darzalex Source text for Eikon: Further company coverage: Our Standards:The Thomson Reuters Trust Principles. Source link
